VT News

Anna Chancellor

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Trump marks 200 days with major policy achievements, including a 'One Big Beautiful Bill' that makes tax cuts permanent and expands border security.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Trump marks 200 days with major policy achievements, including a 'One Big Beautiful Bill' that makes tax cuts permanent and expands border security.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Anna Chancellor

Top Topics

Trending in U.S.

World

Sport